Arrowhead Pharmaceuticals Reports Fiscal 2019 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Arrowhead Pharmaceuticals Corp (ARWR) Misses Q3 EPS by 8c, Revenues Miss
August 5, 2019 4:01 PM EDTArrowhead Pharmaceuticals Corp (NASDAQ: ARWR) reported Q3 EPS of $0.21, $0.08 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $54.37 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Corp (ARWR) click here.
... More